Barriers to Curative Treatment for Early-Stage Liver Cancer, 2010-2021 U.S. Cohort

A retrospective cohort study of 629 patients with early-stage hepatocellular carcinoma seen at two U.S. health systems from January 2010 to July 2021. The research, published on figshare, identifies tumor-specific, clinical, and system-level factors associated with the underuse of curative treatments like resection, ablation, and transplantation.

Use Cases

• Analyzing associations between insurance type and treatment receipt based on the described regression results
• Modeling the impact of liver function (Child-Pugh score) and tumor characteristics on treatment eligibility
• Identifying common system-level barriers to liver transplantation mentioned in the conclusion

Strengths

• Study includes 629 patient records with a defined time range (2010-2021)
• Multivariable analysis provides specific odds ratios for factors like insurance type and tumor size
• Data is openly available under a CC-BY-4.0 license

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count for the underlying data is unknown, which may limit suitability assessment
• The dataset files are supplementary materials (JPG, DOCX), not a primary structured data table

Provenance

Source

figshare admin karger

Collection Method

Retrospective cohort study via medical record review at two U.S. health systems

Time Range

January 2010 to July 2021

Freshness

Last updated 2026-04-16 05:55:16; freshness should be verified

Geography

United States (two health systems)